Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Pals

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Oncogene|January 16, 2013
Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signalingJ Zeilstra, S P J Joosten, H van Andel, et al.
The American Journal of Pathology|March 1, 1997
Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomasP Drillenburg, R van der Voort, G Koopman, et al.
British Journal of Cancer|December 1, 1996
Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG)I Songun, C J van de Velde, J Hermans, et al.
Immunity|December 1, 2001
Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletionR Arens, K Tesselaar, P A Baars, et al.
Leukemia|April 12, 2003
The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myelomaP W B Derksen, D J J de Gorter, H P Meijer, et al.
Leukemia|September 14, 1999
CD44 expression predicts disease outcome in localized large B cell lymphomaP Drillenburg, V J Wielenga, M H Kramer, et al.
Scandinavian Journal of Gastroenterology|March 7, 1998
CD44 splice variants as prognostic markers in colorectal cancerV J Wielenga, R van der Voort, J W Mulder, et al.
The Netherlands Journal of Medicine|March 7, 2013
Guideline for diagnosis and treatment of Waldenström's macroglobulinaemiaJ M I Vos, M C Minnema, P W Wijermans, et al.
Blood Cancer Journal|September 10, 2013
High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sitesW Kraan, H M Horlings, M van Keimpema, et al.
Blood|December 1, 1993
Expression and release of CD27 in human B-cell malignanciesM H van Oers, S T Pals, L M Evers, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Oncogene|January 16, 2013
Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signalingJ Zeilstra, S P J Joosten, H van Andel, et al.
The American Journal of Pathology|March 1, 1997
Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomasP Drillenburg, R van der Voort, G Koopman, et al.
British Journal of Cancer|December 1, 1996
Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG)I Songun, C J van de Velde, J Hermans, et al.
Immunity|December 1, 2001
Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletionR Arens, K Tesselaar, P A Baars, et al.
Leukemia|April 12, 2003
The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myelomaP W B Derksen, D J J de Gorter, H P Meijer, et al.
Leukemia|September 14, 1999
CD44 expression predicts disease outcome in localized large B cell lymphomaP Drillenburg, V J Wielenga, M H Kramer, et al.
Scandinavian Journal of Gastroenterology|March 7, 1998
CD44 splice variants as prognostic markers in colorectal cancerV J Wielenga, R van der Voort, J W Mulder, et al.
The Netherlands Journal of Medicine|March 7, 2013
Guideline for diagnosis and treatment of Waldenström's macroglobulinaemiaJ M I Vos, M C Minnema, P W Wijermans, et al.
Blood Cancer Journal|September 10, 2013
High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sitesW Kraan, H M Horlings, M van Keimpema, et al.
Blood|December 1, 1993
Expression and release of CD27 in human B-cell malignanciesM H van Oers, S T Pals, L M Evers, et al.
Pageof 12